PCSK9 and atherosclerosis: In 2014, two research groups separately described the so-called pro-protein convertase subtilisin/kexin type 9 (PCSK9)-adeno-associated virus (AAV) mice as a quick, adaptable, and cost-effective animal model for atherosclerosis (46).